The global clinical nutrition market reached USD 55.8 billion in 2024 and is forecast to surge to USD 104.6 billion by 2033, growing at a CAGR of 7.2%. This growth is fuelled by rising chronic disease prevalence, technological breakthroughs in personalized and medical nutrition, ageing demographics, and changing dietary habits - all of which are promoting awareness and demand for clinical nutrition solutions.
STUDY ASSUMPTION YEARS
- BASE YEAR: 2024
- HISTORICAL YEAR: 2019–2024
- FORECAST YEAR: 2025–2033
CLINICAL NUTRITION MARKET KEY TAKEAWAYS
- Asia‑Pacific holds the largest regional market share, supported by rising chronic disease burden and expanding healthcare access.
- Infant nutrition remains the top product segment, fulfilling early developmental dietary needs.
- Oral administration leads the route segment due to convenience, safety, and broad acceptance.
- Application-wise, cancer-related nutrition support and malnutrition interventions are fuelling adoption.
- Pediatric end-users dominate demand, driven by high child populations and targeted nutritional formulations.
- Market growth: from USD 55.8 B in 2024 to USD 104.6 B by 2033, at 7.2% CAGR.
MARKET GROWTH FACTORS
- Rising chronic and metabolic diseases:
For chronic and metabolic diseases, clinical nutrition stresses an individual and balanced dietary regimen. The regime has a base of whole foods like fruits, vegetables, legumes, lean protein, and whole grains. Nutrition diminishes saturated fats. Nutrition diminishes sodium (salt). Nutrition diminishes added sugars. Nutrition diminishes refined carbohydrates within. These diets feature fewer calories, increased fiber, and healthy fats like those from nuts, seeds, and fish, in order to control blood sugar, blood pressure, and inflammation. The Mediterranean diet, vegetarian diet, and DASH diet may improve heart health, including potential weight loss. Other important parts of treatment involve exercising, quitting smoking, and managing sleep issues. For inherited metabolic disorders, medical nutrition therapy is highly individualized and involves a restriction of or supplements a specific nutrient under careful medical supervision for managing toxic metabolites and for maintaining good health.
- Aging global population:
The global trend of an aging population will fuel demand for clinical nutrition products. Products are adopted for the treatment of old age-related conditions such as sarcopenia, chronic diseases, malnutrition, cardiovascular diseases, diabetes, cognitive dysfunction, and geriatric frailty. The demand for specialized nutrition and will positively impact the market. Innovation drives market growth. High protein supplements, disease-specific products, ready-to-drink products, functional foods and nutraceuticals for bone health, brain health and digestive health are growing to meet changing consumer needs. Convenience products that are ready to consume at home or on the go are growing among older consumers. As health consciousness increases and nutrition for older adults gains prominence, clinical nutrition products for this population can diversify, serving a range of different nutritionally oriented requirements.
- Advances in personalized nutrition:
Technologies that personalize nutrition involve artificial intelligence, machine learning, genomics, wearable sensors, and gathering mobile health data. Continuous glucose monitors (CGMs), bioinformatics and computational platforms, along with AI-based health applications, do analysis of an individual's genetic, metabolic, and lifestyle information to create personalized nutrition plans with catering to their specific needs. These technologies allow personalized nutrition strategies, enabling predictions of food response and chronic disease management like diabetes or obesity. Integration of multi-omics such as genomic, transcriptomic, proteomic, metabolomic and microbiomic data improves predictions of behavior and health. This is in addition to generic dietary recommendations and personalized dietary interventions which aim to improve health in the long term by targeting outcomes.
Request for a sample copy of this report:
https://www.imarcgroup.com/clinical-nutrition-market/requestsample
MARKET SEGMENTATION
Breakup by Product:
- Infant Nutrition: addresses the dietary needs of newborns with formula and supplements
- Parental Nutrition
- Enteral Nutrition
Breakup by Route of Administration:
- Oral
- Enteral
- Parenteral
Breakup by Application:
- Cancer
- Malnutrition
- Metabolic Disorders
- Gastrointestinal Disorders
- Neurological Disorders
- Others
Breakup by End User:
- Pediatric
- Adults
- Geriatric
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
REGIONAL INSIGHTS
Asia‑Pacific leads the clinical nutrition market, propelled by rapid urbanization, rising chronic disease incidence, and expanding geriatric populations in India and China. With improving healthcare access and higher disposable incomes, demand for specialized nutrition and preventive therapy continues to grow strongly.
RECENT DEVELOPMENTS & NEWS
Recent innovations include Nestlé Health Science’s 2023 partnership with EraCal Therapeutics to develop new nutraceuticals targeting metabolic diseases, reflecting a shift toward functional, health-focused foods. Danone’s May 2024 acquisition of U.S. tube‑feeding specialist Functional Formularies has bolstered its enteral nutrition portfolio and U.S. presence. Friesland Campina Ingredients released Nutri Whey™ ProHeat, a heat-stable whey protein for medical nutrition, showcasing cutting-edge ingredient innovation.
KEY PLAYERS
Abbott Laboratories, B. Braun Melsungen AG, BASF SE, Baxter International Inc., Danone S.A., Fresenius SE & Co. KGaA, Grifols S.A., Koninklijke DSM N.V., Meiji Holdings Co. Ltd., Nestlé S.A., Perrigo Company plc, Reckitt Benckiser Group PLC, etc.
Ask Analyst for Customization:
https://www.imarcgroup.com/request?type=report&id=5995&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St., Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel NoD) +91 120 433 0800
United States: (+1-201971-6302)
Comments (0)